ADO 0.00% 2.1¢ anteotech ltd

Ann: Quarterly Update and Appendix 4C, page-36

  1. 26 Posts.
    lightbulb Created with Sketch. 20
    The word pathetic doesn't cover it..They still havent started the European clinical trial..They have the wrong product at the wrong time managed by the wrong people. Stop all the trial work you are throwing good money after bad..the opportunity has long gone..nobody is buying an instrument to run a test that the world is reading by eye...The sepsis product is going to be another fiasco......The competition are now cashed up since they did get the right Covid product and built their war chests for the next products....
    The Energy business is in the same sorry mess..what happened to all the Collaborators?..No progress reported. Sounds as if they are starting over. Given the massive interest in batteries if ADO had something of interest they would have been locked up long ago by the major players....They not even been paid for a trial or study..Just a lot of academic claims of improvements that the industry yawns at.
    These guys are just playing and paying themselves handsomely to do it....
 
watchlist Created with Sketch. Add ADO (ASX) to my watchlist
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.